Category: Immunology / Pulmonary Fungal Disease
Allergic Bronchopulmonary Aspergillosis (ABPA) is a complex hypersensitivity reaction to the fungus Aspergillus fumigatus, primarily affecting individuals with asthma or cystic fibrosis, leading to recurrent exacerbations, bronchiectasis, and progressive lung damage.
Affects 1-2% of asthmatics and 2-15% of cystic fibrosis patients. (Source: European Respiratory Society)
Discover the latest clinical trials and treatments for Allergic Bronchopulmonary Aspergillosis on JourneyForHealth.
View Full Analysis